TREATING AMENORRHEA IN VITAL ENERGY-DEFICIENT PATIENTS WITH ANGELICA SINENSIS-ASTRAGALUS MEMBRANACEUS MENSTRUATION-REGULATING DECOCTION

Amenorrhea is a common gynecological com-plaint more frequently seen in young women.Re-ports from various sources have appeared of latein which treatment of the disease involved theuse of tonics to restore the patient's health.Theviscera on which emphasis is laid are,however,varied.Most studies were conducted with theKidney as the organ to be reinforced.Next comes     

虚证闭经57例临床观察

闭经一般以虚证为多见。我们对57例辨证为虚证的闭经患者分别采用以补肾为主的“六子汤”和补气血兼补肝肾的“归芪调经汤”治疗,以观察其疗效。临床资料:初潮年龄:最小12岁,最大20岁。12～15岁28人,16～20岁29人,半数左右的对象初潮年龄大于我国城市妇女平均初潮年龄。月经史:月经异常者46人,主要表现为月经后期。婚姻:已婚7人,未婚50人。     

化瘀通腑法治疗子宫内膜异位症临床及实验研究

用化瘀通腑的内异1号丸治疗盆腔子宫内膜异位症76例,总有效率为80.26%。治疗前后分别作实验室检验,结果血液流变学包括全血比粘度(低切比)、红细胞聚集指数、全血还原粘度、血沉、血沉方程 K 值、血浆比粘度均有显著改变(P<0.05),血清IgA,IgG、IgM、C_3均有显著下降(P<0.001),OKT_8升高,OKT_4/OKT_8下降(P<0.001),经期血浆 PGF_(2a)下降(P<0.001)。提示化瘀通腑法和它的代表方内异1号丸具有改变血液流变性、改善微循环、调整机体免疫功能和降低经期血浆前列腺素浓度的作用,从而使患者的临床症状和体征得到改善。     

龙胆泻肝汤治疗多囊卵巢综合征

多囊卵巢综合征是明代医学的病名,临床表现主要为月经不调、闭经、功血、不育、毛发增多、体形壮实或肥胖等症状和体征。常用的诊断方法为盆腔气腹造影或腹腔镜检查。根据中医辨证,本病属实证者多,且表现为肝旺症状,因此,我们采用龙胆泻肝汤以清泄肝火,摸索治疗本病的规律和疗效。现将治疗满3个月以上的20例分析如下:临床资料20例中18例临床表现以闭经为主(Ⅰ度闭经17例,另1例未做孕酮撤血试验),2例主要表现为无排卵型子宫出血。年龄:最小20岁,最大28岁,平均年龄为24.7岁。     

活血化瘀法治疗子宫内膜异位症12例临床观察

我科从1986～1987年,采用口服活血化瘀中药及丹参静脉滴注为主的多途径给药治疗12例子宫内膜异位症住院患者。取得一定疗效。小结如下。临床资料12例患者年龄在26～40岁之间,平均33.6岁。已婚11例.有不育史者4例,占已婚妇女的36.36%,其中2例各有一次流产病史。病程最短2个月,最长16年。12例中有4例在发病前2年内接受过人工流产术。皆有剧烈的经期和/或平时腹痛症状,有肛门坠     

“内异灵片”治疗子宫内膜异位症的临床研究

用化瘀通腑、软坚散结法制成内异灵片治疗子宫内膜异位症患34例，同时设立西药（Tamoxifen)对照组18例。观察结果表明，内异灵片能显提高内异症患NK细胞的活性，调整T细胞的功能，维持人体免疫功能的稳定、改善患的各组症状和体征，临床有效率与Tamoxifen相仿。     

归芪调经汤治疗虚性闭经临床研究

闭经是妇科常见病,较多见于青年妇女,常给患者身心健康带来不良影响。近年来各地运用补法治疗闭经的报道日益见多,但侧重面各有不同,其中以补肾法的研究最为突出,其次为补脾法。我们根据临床实践,制定出以补     

内异Ⅱ号对子宫内膜异位症β-内啡肽、强啡肽的影响

检测正常妇女及子宫内膜异位症患者经期血浆β-内啡肽、强啡肽水平及其动物模型下丘脑、垂体β-内啡肽、强啡肽水平。结果表明:子宫内膜异位症患者β-内啡肽、强啡肽水平低于正常妇女,可能是痛经的原因之一,内异Ⅱ号缓解痛经的作用,有部分可能是通过提高外周血及下丘脑β-内啡肽水平;子宫内膜异位症动物模型下丘脑、垂体β-内啡肽、强啡肽水平与正常对照组相比有明显的不同。     

化瘀通腑法治疗子宫内膜异位症的临床及实验研究——附95例病例分析

本文以大黄、鳖甲、琥珀组成化瘀通腑的内异Ⅰ号丸治疗此病取得较好的效果。通过临床及动物实验证实,它的功效主要是通过改善全身和局部微循环,促使病灶吸收;降低前列腺素使疼痛减轻,有利于生育;通过T 细胞亚群百分率的变化来调节控制机体的免疫功能,达到阻断病交发展的目的。     

Study on Therapeutic Mechanism of Neiyifang (内异方) in Treating Endometriosis

Objective: To observe the clinical effect of Neiyifang (内异方,NYF) in treating endometri-osis and to explore its therapeutic mechanism through observing its influence on plasma β-endorphin β-EP) in different menstrual stages and levels of prostaglandins (PGs) in menstruation. Methods: NYF was administered to 104 patients with endometriosis one dose daily with 3 successive menstrual cycles as one therapeutic course. Peripheral blood β-EP level in follicular, luteal and menstrual stages, as well as PGF2a, PGE2, thromboxane B2 and 6-keto-PGF1a levels in menstrual stage were detected by RIA, and controlled with those in 15 healthy persons. Results: (1) The total effective rate of NYF was 81. 3% and it showed significant effect in improving patients' clinical symptoms and physical signs; (2) In menstrual stage, the levels of β-EP, 6-keto-PGF1α/ TXB2 were lower(P<0.05) and levels of PGF2a, PGE2, TXB2 and 6-keto-PGF1α, were higher (P<0. 05) in patients than those in control, and the higher the level of